vector-delivered heat shock H11 kinase gene therapy (Vasade)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namevector-delivered heat shock H11 kinase gene therapy (Vasade)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionHeat shock protein beta-8 stimulants
TargetsHeat shock protein beta-8
Therapy Area/IndicationsMyocardial Ischemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVasade Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVasade Biosciences Inc
Active IndicationsN/A
Inactive IndicationsMyocardial Ischemia

Other Information

ATC CodeN/A
Related LinksN/A